Collegium Pharmaceutical, Inc. (COLL)
45.14
0.00 (0.00%)
USD |
NASDAQ |
Feb 12, 16:00
45.14
0.00 (0.00%)
After-Hours: 20:00
Collegium Pharmaceutical Enterprise Value : 2.057B for Feb. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Hims & Hers Health, Inc. | 4.288B |
| Alnylam Pharmaceuticals, Inc. | 42.63B |
| Corcept Therapeutics, Inc. | 3.880B |
| Catalyst Pharmaceuticals, Inc. | 2.254B |
| Johnson & Johnson | 607.54B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 31.51M |
| Revenue (Quarterly) | 209.36M |
| Total Expenses (Quarterly) | 177.85M |
| EPS Diluted (Quarterly) | 0.8385 |
| Gross Profit Margin (Quarterly) | 61.70% |
| Profit Margin (Quarterly) | 15.05% |
| Earnings Yield | 3.56% |
| Operating Earnings Yield | 9.51% |
| Normalized Earnings Yield | 3.791 |